| Literature DB >> 28179968 |
Yukio Kadokawa1, Kazuhiro Katayama2, Kozo Takahashi1, Nobuhisa Fukushima1, Setsu Tanaka3, Yuko Taniguchi4, Takatoshi Nawa2, Mitsuru Sakakibara2, Kazuyoshi Ohkawa2.
Abstract
BACKGROUND: We have been conducting liver disease education classes regularly in our hospital for the purpose of providing health information to patients and their families.Entities:
Keywords: Branched-chain amino acid; Cancer; Knowledge level; Nutrition; Repeated education
Year: 2017 PMID: 28179968 PMCID: PMC5289140 DOI: 10.14740/jocmr2914w
Source DB: PubMed Journal: J Clin Med Res ISSN: 1918-3003
Knowledge Degree of Patients and Family and the Times of Experience to Attend Classrooms
| Tips of information/times of experience of classroom | Patients | Family | P value |
|---|---|---|---|
| Prophylaxis of HC | |||
| 0 | 1.00 ± 0.82 | 0.67 ± 0.49 | 0.3034 |
| 1 - 2 | 1.36 ± 0.78 | 1.30 ± 0.48 | 0.7027 |
| ≥ 3 | 2.30 ± 0.48 | 1.67 ± 0.57 | 0.0958 |
| Treatment of HC | |||
| 0 | 1.33 ± 1.16 | 0.75 ± 0.71 | 0.3305 |
| 1 - 2 | 1.27 ± 0.96 | 0.83 ± 0.41 | 0.2824 |
| ≥ 3 | 2.00 ± 0.63 | 2.00 | > 0.99 |
| Iron restriction | |||
| 0 | 1.00 ± 0.89 | 0 ± 0 | 0.0258 |
| 1 - 2 | 1.17 ± 0.39 | 1.00 ± 0 | 0.4631 |
| ≥ 3 | 2.75 ± 0.50 | 1.50 ± 0.71 | 0.0801 |
| Effects of BCAA | |||
| 0 | 0.60 ± 0.70 | 0.17 ± 0.58 | 0.0521 |
| 1 - 2 | 0.85 ± 0.66 | 0.56 ± 0.73 | 0.2278 |
| ≥ 3 | 2.30 ± 0.68 | 1.33 ± 0.58 | 0.0564 |
Comparisons were performed using Mann-Whitney test. Data were shown as mean ± SD. HC: hepatic cancer; BCAA: branched-chain amino acid.
Figure 1Relationship between knowledge degree just before the lecture and times of attendance to classroom for liver diseases. Because comparison (Kurskal-Wallis) of multi-groups revealed significant difference in (a) (P < 0.0001), (b) (P = 0.0388), (c) (P = 0.0021), and (d) (P < 0.0001), Mann-Whitney test was conducted. P values by Mann-Whitney test are indicated. (a) Prophylaxis of hepatic cancer. (b) Treatment of hepatic cancer. (c) Significance of iron restrictions in the C type liver disease. (d) Significance of BCAA.
Changes of Knowledge Degree of Participants by Attending Classrooms
| Tips of information/times of experience of classroom | Patients | Family | P value |
|---|---|---|---|
| Prophylaxis of HC | |||
| 0 | 0.76 ± 0.63 | 2.05 ± 0.38 | < 0.0001 |
| 1 - 2 | 1.34 ± 0.71 | 2.09 ± 0.45 | < 0.0001 |
| ≥ 3 | 2.07 ± 0.62 | 2.54 ± 0.52 | 0.0956 |
| Treatment of HC | |||
| 0 | 0.91 ± 0.83 | 2.00 ± 0.0 | 0.0339 |
| 1 - 2 | 1.14 ± 0.85 | 1.91 ± 0.54 | 0.0114 |
| ≥ 3 | ND | ND | ND |
| Iron restriction | |||
| 0 | 0.54 ± 0.78 | 2.31 ± 0.63 | 0.0012 |
| 1 - 2 | 1.13 ± 0.35 | 2.54 ± 0.52 | 0.0017 |
| ≥ 3 | 2.14 ± 0.90 | 3.00 ± 0.0 | 0.0633 |
| Effects of BCAA | |||
| 0 | 0.32 ± 0.63 | 1.86 ± 0.56 | < 0.0001 |
| 1 - 2 | 0.78 ± 0.68 | 1.85 ± 0.71 | < 0.0001 |
| ≥ 3 | 2.00 ± 0.78 | 2.46 ± 0.69 | 0.0588 |
Comparisons were performed using Wilcoxon test. Data were shown as mean ± SD. HC: hepatic cancer; BCAA: branched-chain amino acid; ND: not determined because small number of subjects.